Published in Oncogene on August 08, 2011
The promise of anti-ErbB3 monoclonals as new cancer therapeutics. Oncotarget (2012) 1.25
Targeting of erbB3 receptor to overcome resistance in cancer treatment. Mol Cancer (2014) 1.22
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylation. Neoplasia (2013) 0.93
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs). Oncotarget (2015) 0.92
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. Transl Oncol (2013) 0.92
Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Res (2013) 0.86
Combining anti-ERBB3 antibodies specific for domain I and domain III enhances the anti-tumor activity over the individual monoclonal antibodies. PLoS One (2014) 0.81
Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3. Hum Vaccin Immunother (2015) 0.81
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. Oncogenesis (2014) 0.78
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds. MAbs (2016) 0.77
The anti-HER3 (ErbB3) therapeutic antibody 9F7-F11 induces HER3 ubiquitination and degradation in tumors through JNK1/2- dependent ITCH/AIP4 activation. Oncotarget (2016) 0.75
HER-3: hub for escape mechanisms. Aging (Albany NY) (2015) 0.75
Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene (1995) 4.10
Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol (1988) 3.92
Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection. J Clin Microbiol (2000) 3.48
Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology (1996) 2.98
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients. Science (1995) 2.79
Epidemiology of nosocomial infection in 125 Italian intensive care units. Minerva Anestesiol (2010) 2.76
Expression of Ia-like antigens in normal human nonlymphoid tissues. Transplantation (1981) 2.29
Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology (1994) 2.20
Distant metastases in ovarian carcinoma. Int J Gynecol Cancer (2003) 2.20
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene (2000) 2.08
Cerebrospinal fluid study in paraneoplastic syndromes. J Neurol Neurosurg Psychiatry (2009) 1.96
The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer (1991) 1.95
Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum (2005) 1.94
Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? J Clin Gastroenterol (2001) 1.83
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol (1994) 1.79
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther (1994) 1.79
Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus. Clin Diagn Lab Immunol (1997) 1.78
Aortic arch anomalies are associated with increased risk of neurological events in carotid stent procedures. Eur J Vasc Endovasc Surg (2007) 1.73
Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation (1998) 1.73
A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol (1989) 1.73
The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer (2000) 1.71
Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res (2000) 1.70
Human-threatened ecosystem: new signs of groundwater connection between Yacyreta reservoir and Ibera wetland (South America). Sci Total Environ (2005) 1.70
Detection and preliminary characterization of a new rabbit calicivirus related to rabbit hemorrhagic disease virus but nonpathogenic. J Virol (1996) 1.69
The role of reproductive and menstrual factors in cancer of the breast before and after menopause. Eur J Cancer (1996) 1.67
Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci U S A (1993) 1.64
Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases. Nature (1984) 1.62
Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile. Virus Res (1997) 1.61
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Alpha 6 beta 4 and alpha 6 beta 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res (1997) 1.58
Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer (1981) 1.55
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol (2001) 1.54
3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity. J Virol (1995) 1.53
Eosinophilic gastroenteritis with ascites: a case report and review of the literature. Dig Dis Sci (2003) 1.51
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer (2000) 1.50
Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia (2008) 1.49
Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus. J Virol (1994) 1.48
Effectiveness and efficiency of intensive care medicine: variable costs in different diagnosis groups. Acta Anaesthesiol Scand (2004) 1.46
Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res (1999) 1.46
Proposal of a flexible structural-organizing model for the Intensive Care Units. Minerva Anestesiol (2007) 1.45
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol (2000) 1.44
Morphological, immunochemical, and biochemical study of rabbit achilles tendon at various ages. J Bone Joint Surg Am (1980) 1.43
Flavonoids from Dittrichia viscosa. Planta Med (1982) 1.42
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma. J Pathol (2001) 1.41
Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J (1991) 1.40
Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res (2000) 1.40
Chronic traumatic aneurysms of the descending thoracic aorta. Tex Heart Inst J (1985) 1.39
[Congresses and ethical problems]. G Ital Cardiol (1992) 1.39
Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res (2000) 1.35
Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer (1996) 1.35
Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res (1985) 1.35
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci U S A (1984) 1.32
The secreted tumor-associated antigen 90K is a potent immune stimulator. J Biol Chem (1994) 1.32
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Comparative study of antibodies to native and denatured DNA. J Immunol (1970) 1.29
Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res (2001) 1.29
Experimental skin lesions in mice resembling systemic lupus erythematosus. Arthritis Rheum (1973) 1.27
Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res (1984) 1.26
Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res (1983) 1.25
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res (1986) 1.24
Antigenicity of the rabbit hemorrhagic disease virus studied by its reactivity with monoclonal antibodies. Virus Res (1995) 1.23
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol (2005) 1.22
Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding. Eur J Immunol (1997) 1.22
End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res (1994) 1.22
Changes in Ia-like antigen expression on malignant human cells. Immunogenetics (1981) 1.22
Repetitive sequences cloned from Leptospira interrogans serovar hardjo genotype hardjoprajitno and their application to serovar identification. J Clin Microbiol (1992) 1.20
The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20
Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene (2012) 1.20
Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med (1991) 1.19
Anthracyclines: selected new developments. Curr Med Chem Anticancer Agents (2001) 1.18
Role of interleukins 1 and 2 on human thymocyte mitogen activation. Cell Immunol (1981) 1.17
Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci (2003) 1.15
Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat (2001) 1.15
Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett (2000) 1.15
Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope. Am Heart J (1994) 1.14
Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol (1990) 1.14
The Trop-2 signalling network in cancer growth. Oncogene (2012) 1.14
Experimental renal disease induced by DNA-anti-DNA immune complexes. J Clin Invest (1972) 1.13
Expression of HL-A antigens in synchronized cultures of human lymphocytes. J Immunol (1972) 1.12
Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics (1984) 1.12
Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. Cancer Res (1988) 1.12
Neonatal problems of late and moderate preterm infants. Semin Fetal Neonatal Med (2012) 1.12
Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies. Clin Diagn Lab Immunol (1994) 1.11
Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis (2010) 1.11
Diagnostic and prognostic value of peritoneal immunocytology in gastric cancer. J Clin Oncol (1998) 1.10
Detection and identification of Leptospira interrogans serovars by PCR coupled with restriction endonuclease analysis of amplified DNA. J Clin Microbiol (1994) 1.10
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10